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Sera raised against hree synthetic peptides that reproduce sequences of the pro-nerve powth factor (proNGF) protein 
were tested in immunoprecipitation experiments using in vitro translation products of SP6-directed NGF mRNA in a 
rabbit reticulocyte lysate. The interaction of these antibodies with bacterially synthesixed chimeric preproNGF was also 
examined. Digestion of the translation products by the y-subunit generated the 22 and 18 kDa intermediates. A predomi- 
nant 13 kDa intermediate was obtained after digestion of translation products in wheat germ extract. This is shown to 
be the N-terminal peptide by immunoprecipitation with an anti-peptide serum. These antibodies may be used to detect 
NGF precursor cleavage products in vivo. 
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1. INTRODUCTION 
The nucleotide sequence derived from the mouse 
submandibular gland (MSG) nerve growth factor 
(NGF) cDNA predicted an NGF precursor (prepro- 
NGF) of about 35 kDa which may be cleaved at di- 
basic residues to generate three additional peptides 
besides the NGF protein which is situated at the 
carboxyl terminus [1,2] (fig. 1). Four different NGF 
mRNA species that diverge at their amino termini 
were identified, a result of alternative splicing 
and/or initiation from independent promotors [3]. 
They would generate, besides the 35 kDa precur- 
sor, another species of about 29 kDa. 
Our antisera to NGF do not recognize the NGF 
precursor [4,5]. Therefore, in order to biochemi- 
cally characterize this protein and to identify cell 
types that synthesize it, our strategy consisted of 
raising antibodies to synthetic peptides that re- 
produce sequences of this molecule. A protein of 
about 31 kDa, the putative NGF precursor, was 
immunoprecipitated by an anti-peptide serum in 
MSG and thyroid extracts [6]. Using affinity- 
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purified immunoglobulins to these peptides, we 
localized proNGF-like immunoreactivity in the 
MSG [6,7], rat thyroid [6], and in neurons of the 
hippocampus, cortex and septum as well as in other 
regions of the rat brain [8]. 
In the present report we examined the interaction 
of these sera with in vitro synthesized NGF precur- 
sors from SPddirected NGF mRNAs and with 
bacterially synthesized chimeric preproNGF. 
2. MATERIALS AND METHODS 
Peptide NZ corresponds to the sequence - 163 to - 139, N4 to 
the sequence - 71 to - 45 and Ns to the sequence - 49 to - 40 
of the NGF precursor (see fig.3, [2]). Rabbits were immunized 
Fig. 1. Schematic representation of preproNGF cDNA and pro- 
tein. The box indicates the precursor protein, the solid box 
shows the ,&NGF and the thin line the untranslated regions. Ar- 
rows indicate possible cleavage sites. Hatched boxes correspond 
to epitopes reproduced by the synthetic peptides. 
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with peptides coupled to keyhole limpet hemocyanin [7]. Titers 
of the sera were between 1 x lo-’ and 2 x 10m6 for their cor- 
responding peptide as tested by ELISA techniques using preim- 
mune sera for controls [7,9]. 
The Smal-P&I fragment of the mouse NGF cDNA (gift of 
Drs M. Selby and W. Rutter) was subcloned into the SP65 vec- 
tor using standard techniques [lo]. The recombinant DNA was 
linearized by PstI and transcribed by SP6 polymerase (Pro- 
mega/Biotec) according to the manufacturer’s instructions. 
Capping of the NGF mRNA was done as in [l 11. NGF mRNA 
was extracted with phenol/chloroform/isoamyl/alcohol, 
precipitated with ethanol and translated in a rabbit reticulocyte 
lysate or in a wheat germ extract (Promega/Biotec) 
The bacterial clone expressing the chimeric preproNGF pro- 
tein [9] was grown in M9 medium [lo] with 1 mM IPTG and 
[35S]sulfate (5&i/ml). Purification of the chimeric protein was 
done by, APTG-Sepharose chromatography. [9]. 
In vitro translation products of purified chimeric protein were 
incubated with 10 ,uI of serum in 300 ,~l of buffer A (0.1 M Tris, 
pH 8.2, 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 
0.5% Na deoxycholate, 0.1% ovalbumin) and 100 ~1 of protein 
A-Sepharose with gentle agitation overnight at 4°C. The suspen- 
sion was washed with 4 ml of buffer B (buffer A, 0.5 M LiCl). 
Elution of bound material, gel electrophoresis and autoradiog- 
raphy were done as before [4,6]. Digestion with the y-subunit 
was done in 0.1 M Tris, pH 7.6, at 37°C for 1 h. 
3. RESULTS AND DISCUSSION 
In vitro translation of SPdderived NGF mRNAs 
gave rise to two species of about 35 and 29 kDa 
which probably correspond to NGF precursors in- 
itiated from the first and the second AUG, respec- 
tively (fig.2, lane 2; fig.3, lane 4). Translational ef- 
ficiency in the wheat germ extract was significantly 
reduced for uncapped NGF mRNA (fig.3, lane 3). 
These in vitro synthesized precursors constitute a 
convenient substrate to test the specificity of the 
sera to proNGF peptides. As shown in fig.2A, anti- 
N3 and anti-N4 sera immunoprecipitated both 
species (lanes 4 and 5) while the anti-N2 serum im- 
munoprecipitated primarily the 35 kDa species 
(lane 6). 
We previously described a bacterial clone syn- 
thesizing a ,&galactosidase-fused preproNGF [9]. 
Purification by APTG-Sepharose from a bacterial 
extract yields the chimeric protein and a degrada- 
tion product (fig.2B, lane 2). The anti-N2 serum 
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Fig.2. (A) Translation of SP6-directed NGF mRNAs in a rabbit reticulocyte lysate. Lanes: (1) no mRNA; (2) SP6-derived NGF mRNA; 
immunoprecipitation of translation products by: (3) preimmune serum; (4) anti-N3 serum; (5) anti-N4 serum; and (6) anti-N2 serum. 
(B) Lanes: (1) bacterial extract; (2) material purified by APTG-Sepharose chromatography; immunoprecipitation of 2 by: (3) anti-N2 
serum; (4) preimmune serum; (5) anti-N4 serum; and (6) anti-N3 serum. 
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Fig.3. Processing of the in vitro translation products by the rsubunit. Lanes: (1) translated SP&derived NGF mRNA; (2) after digestion 
by the y-subunit; (3) uncapped NGF mRNA translated in a wheat germ extract; (4) capped NGF mRNA translated as in 3; (5) after 
digestion by the y-subunit; immunoprecipitation of the y-subunit digests by: (6) anti-N2 serum; (7) anti-N4 serum; (8) anti-NGF serum; 
(9) preimmune serum; and (10) iodinated, purified BNGF. 
(lane 3) and to a lesser degree the anti-N3 serum 
(lane 6) immunoprecipitated this protein, while the 
anti-N4 serum (lane 5) did not cross-react sug- 
gesting that the epitope reproduced by the N4 pep- 
tide is probably ‘masked’ in the chimeric protein. A 
comparable pattern of interaction was also observ- 
ed when using ELISA techniques [9]. 
In the MSG, the NGF is associated with the y- 
subunit [ 12,131, which is an arginine esteropep- 
tidase and whose role in the maturation of proNGF 
is controversial. This is due to the fact that several 
cells or tissues which synthesize NGF do not syn- 
thesize the y-subunit, e.g. mouse fibroblast L929 
cells [14,15], mouse and rat iris [16] and the pros- 
tate of the guinea pig [ 171. Most probably, in these 
systems a different protease than the y-subunit is 
involved in the NGF processing. Digestion at 
cleavage sites 1, 2 and 3 would yield NGF- 
containing intermediates of 22, 18 and 13 kDa, 
respectively. Digestion of the NGF precursors syn- 
thesized in a reticulocyte lysate yielded the 22 and, 
to a lesser degree, the 18 kDa intermediates (fig.3, 
lane 2). Detection of the 13 kDa species is obscured 
by co-migration of lysate material in this area of 
the gel. Digestion of the NGF precursors synthesiz- 
ed in a wheat germ extract yielded primarily a 
13 kDa peptide. This is not the ,&NGF but rather 
the N-terminal peptide cleaved at site 1, since it is 
immunoprecipitated by an anti-N2 serum (lane 6) 
but not by the anti-N4 or the anti-NGF sera (lanes 
7,8). Digestion of the chimeric preproNGF with the 
y-subunit did not liberate the ,BNGF protein either 
(results not shown). These results suggest that in
vitro-synthesized or bacterially synthesized NGF 
precursors are abnormally folded and unspecifical- 
ly degraded by the y-subunit. Abnormal digestion 
of in vitro-synthesized NGF precursors was recent- 
ly suggested by others [18,19]. However, in this 
report, using the anti-N2 serum, we provide direct 
evidence that the 13 kDa species generated by the 
y-subunit is the N-terminal peptide and not the 
,BNGF. These anti-peptide sera may therefore be 
useful to monitor NGF precursor-processed pep- 
tides in vivo. 
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